guest ::
| Home > Publications database > Tumour mutational burden: clinical utility, challenges and emerging improvements > print |
| Home > Publications database > Tumour mutational burden: clinical utility, challenges and emerging improvements > print |
| 001 | 292496 | ||
| 005 | 20250314142132.0 | ||
| 024 | 7 | _ | |a 10.1038/s41571-024-00932-9 |2 doi |
| 024 | 7 | _ | |a 1759-4774 |2 ISSN |
| 024 | 7 | _ | |a 1759-4782 |2 ISSN |
| 024 | 7 | _ | |a altmetric:166728421 |2 altmetric |
| 024 | 7 | _ | |a pmid:39192001 |2 pmid |
| 037 | _ | _ | |a DKFZ-2024-01743 |
| 082 | _ | _ | |a 610 |
| 100 | 1 | _ | |a Budczies, Jan |0 0000-0002-6668-5327 |b 0 |
| 245 | _ | _ | |a Tumour mutational burden: clinical utility, challenges and emerging improvements |
| 260 | _ | _ | |a New York, NY |c 2024 |b Nature Publ. Group |
| 336 | 7 | _ | |a article |2 DRIVER |
| 336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
| 336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1739176556_9927 |2 PUB:(DE-HGF) |x Review Article |
| 336 | 7 | _ | |a ARTICLE |2 BibTeX |
| 336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
| 336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
| 500 | _ | _ | |a 2024 Oct;21(10):725-742 |
| 536 | _ | _ | |a 314 - Immunologie und Krebs (POF4-314) |0 G:(DE-HGF)POF4-314 |c POF4-314 |f POF IV |x 0 |
| 588 | _ | _ | |a Dataset connected to CrossRef, Journals: inrepo02.dkfz.de |
| 700 | 1 | _ | |a Kazdal, Daniel |0 0000-0001-8187-3281 |b 1 |
| 700 | 1 | _ | |a Menzel, Michael |b 2 |
| 700 | 1 | _ | |a Beck, Susanne |b 3 |
| 700 | 1 | _ | |a Kluck, Klaus |b 4 |
| 700 | 1 | _ | |a Altbürger, Christian |0 0000-0002-4545-2719 |b 5 |
| 700 | 1 | _ | |a Schwab, Constantin |b 6 |
| 700 | 1 | _ | |a Allgäuer, Michael |b 7 |
| 700 | 1 | _ | |a Ahadova, Aysel |0 P:(DE-He78)07eef6d38a91f4642c810745c5bf5000 |b 8 |u dkfz |
| 700 | 1 | _ | |a Kloor, Matthias |0 P:(DE-He78)028ee60cca729028708496826f077b58 |b 9 |u dkfz |
| 700 | 1 | _ | |a Schirmacher, Peter |b 10 |
| 700 | 1 | _ | |a Peters, Solange |b 11 |
| 700 | 1 | _ | |a Krämer, Alwin |0 P:(DE-He78)493c5fbf69f1b20df6f048712f3ad4a0 |b 12 |u dkfz |
| 700 | 1 | _ | |a Christopoulos, Petros |b 13 |
| 700 | 1 | _ | |a Stenzinger, Albrecht |b 14 |
| 773 | _ | _ | |a 10.1038/s41571-024-00932-9 |0 PERI:(DE-600)2491414-9 |n 10 |p 725-742 |t Nature reviews / Clinical oncology |v 21 |y 2024 |x 1759-4774 |
| 856 | 4 | _ | |u https://inrepo02.dkfz.de/record/292496/files/s41571-024-00932-9.pdf |
| 856 | 4 | _ | |u https://inrepo02.dkfz.de/record/292496/files/s41571-024-00932-9.pdf?subformat=pdfa |x pdfa |
| 909 | C | O | |p VDB |o oai:inrepo02.dkfz.de:292496 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 8 |6 P:(DE-He78)07eef6d38a91f4642c810745c5bf5000 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 9 |6 P:(DE-He78)028ee60cca729028708496826f077b58 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 12 |6 P:(DE-He78)493c5fbf69f1b20df6f048712f3ad4a0 |
| 913 | 1 | _ | |a DE-HGF |b Gesundheit |l Krebsforschung |1 G:(DE-HGF)POF4-310 |0 G:(DE-HGF)POF4-314 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-300 |4 G:(DE-HGF)POF |v Immunologie und Krebs |x 0 |
| 914 | 1 | _ | |y 2024 |
| 915 | _ | _ | |a Nationallizenz |0 StatID:(DE-HGF)0420 |2 StatID |d 2023-08-19 |w ger |
| 915 | _ | _ | |a DEAL Nature |0 StatID:(DE-HGF)3003 |2 StatID |d 2023-08-19 |w ger |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2023-08-19 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2023-08-19 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2023-08-19 |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0113 |2 StatID |b Science Citation Index Expanded |d 2023-08-19 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2023-08-19 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0160 |2 StatID |b Essential Science Indicators |d 2023-08-19 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1110 |2 StatID |b Current Contents - Clinical Medicine |d 2023-08-19 |
| 915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b NAT REV CLIN ONCOL : 2022 |d 2023-08-19 |
| 915 | _ | _ | |a IF >= 70 |0 StatID:(DE-HGF)9970 |2 StatID |b NAT REV CLIN ONCOL : 2022 |d 2023-08-19 |
| 920 | 1 | _ | |0 I:(DE-He78)D470-20160331 |k D470 |l KKE Angewandte Tumorbiologie |x 0 |
| 920 | 1 | _ | |0 I:(DE-He78)A360-20160331 |k A360 |l KKE Mol. Hämatologie/Onkologie |x 1 |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a I:(DE-He78)D470-20160331 |
| 980 | _ | _ | |a I:(DE-He78)A360-20160331 |
| 980 | _ | _ | |a UNRESTRICTED |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|